NanoViricides
NNVC
#10551
Rank
โ‚น3.32 B
Marketcap
โ‚น130.12
Share price
-4.13%
Change (1 day)
-20.81%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): -โ‚น39.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น41.77. In 2025 the company made an earnings per share (EPS) of -โ‚น59.81 an increase over its 2024 EPS that were of -โ‚น66.46.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น39.14-34.57%
2025-โ‚น59.81-10%
2024-โ‚น66.46-5.41%
2023-โ‚น70.265.71%
2022-โ‚น66.46-13.58%
2021-โ‚น76.90-66.11%
2020-โ‚น226.911.7%
2019-โ‚น223.11-10.98%
2018-โ‚น250.64-22.35%
2017-โ‚น322.80-10.53%
2016-โ‚น360.77375%
2015-โ‚น75.95-85.19%
2014-โ‚น512.6842.11%
2013-โ‚น360.7726.67%
2012-โ‚น284.82-6.25%
2011-โ‚น303.8114.28%
2010-โ‚น265.83100%
2009-โ‚น132.92-0%
2008-โ‚น132.92-33.33%
2007-โ‚น199.37-0%
2006-โ‚น199.374445.07%
2005-โ‚น4.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-โ‚น246.84 490.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น120.15-387.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น431.03-1,131.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น303.58-826.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น144.31 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น136.71 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA